Tetralogy of fallot primary prevention: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(Created page with "__NOTOC__ {{ Tetralogy of fallot}} {{CMG}}; {{AE}} {{Fs}} ==Overview== There are no established measures for the primary prevention of [disease name]. OR There are no avail...")
 
No edit summary
 
Line 4: Line 4:


==Overview==
==Overview==
There are no established measures for the primary prevention of [disease name].
There are no established measures for the primary prevention of Tetralogy of Fallot.
 
OR
 
There are no available vaccines against [disease name].
 
OR
 
Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].
 
OR
 
[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3].


==Primary Prevention==
==Primary Prevention==
There are no established measures for the primary prevention of [disease name].
There are no established measures for the primary prevention of Tetralogy of Fallot.
 
===Prevention of Cyanosis===
OR
The following factors may reduce [[systemic vascular resistance]] ([[SVR]]) and exacerbate shunting which in turn exacerbate cyanosis and should be avoided if at all possible:<ref name="pmid13386206">{{cite journal |vauthors=CRAIG JM, DARLING RC, ROTHNEY WB |title=Total pulmonary venous drainage into the right side of the heart; report of 17 autopsied cases not associated with other major cardiovascular anomalies |journal=Lab. Invest. |volume=6 |issue=1 |pages=44–64 |date=1957 |pmid=13386206 |doi= |url=}}</ref>
 
There are no available vaccines against [disease name].
 
OR


Effective measures for the primary prevention of [disease name] include:
*[[Acidosis]]
*[Measure1]
*Bathing in hot water
*[Measure2]
*[[Fever]]
*[Measure3]
* Stress
*[[Infection]]
*Posture (upright, not squatting)
*[[Exercise]]
*[[Beta-adrenergic agonists]]
*[[Dehydration]]
*Closure of the [[patent ductus arteriosus]]


OR
===Prevention of Infective Endocarditis===


[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include:
*[[Antibiotic]] [[prophylaxis]] should be administered.
*[Strategy 1]
*[Strategy 2]
*[Strategy 3]


<br />
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Latest revision as of 18:17, 14 April 2020

Tetralogy of fallot Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Tetalogy of Fallot from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural history, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiography

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

ACC/AHA Guidelines for Evaluation and Follow-up


Tetralogy of fallot primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tetralogy of fallot primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Tetralogy of fallot primary prevention

CDC on Tetralogy of fallot primary prevention

Tetralogy of fallot primary prevention in the news

Blogs on Tetralogy of fallot primary prevention

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Tetralogy of fallot primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

Overview

There are no established measures for the primary prevention of Tetralogy of Fallot.

Primary Prevention

There are no established measures for the primary prevention of Tetralogy of Fallot.

Prevention of Cyanosis

The following factors may reduce systemic vascular resistance (SVR) and exacerbate shunting which in turn exacerbate cyanosis and should be avoided if at all possible:[1]

Prevention of Infective Endocarditis


References

  1. ↑ CRAIG JM, DARLING RC, ROTHNEY WB (1957). "Total pulmonary venous drainage into the right side of the heart; report of 17 autopsied cases not associated with other major cardiovascular anomalies". Lab. Invest. 6 (1): 44–64. PMID 13386206.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Tetralogy_of_fallot_primary_prevention&oldid=1604639"